• linkedin
  • Increase Font
  • Sharebar

    Lumenis launches powerful laser for urologic applications

    Lumenis Ltd. has announced the U.S. launch of the Lumenis Pulse 120H Holmium laser platform for a range of urologic applications.

    The Pulse 120H is designed to provide urologists with a single solution for enhanced vaporization, enucleation, flexible ureteroscopy, and percutaneous nephrolithotomy procedures.

    The laser platform is accompanied by a range of new fibers and accessories, enabling improved clinical outcomes, reduced treatment time, and increased patient satisfaction, according to Lumenis. They include:

    • the Xpeeda fiber, which improves energy utilization and accelerates vaporization rate

    • the SlimLine 200 fiber, which Lumenis says sets new standards for flexibility, efficiency, and durability, thus improving Stone-Dusting capabilities

    • the VersaCut+ Tissue Morcellator, which is safer, faster, more intuitive, and cost-effective, the company says

    • a new simulator designed to train urologists on the HoLEP procedure

    • the HoLEP Disposables Kit, which contains all needed HoLEP instruments in a single package.

    “We strongly believe that with this new set of tools we have the right answers for reducing procedure time, while enhancing procedures' safety and efficacy to address the needs of all the major stakeholders in the health care industry: patients, physicians, providers, and insurers," said Lumenis CEO Tzipi Ozer-Armon.

    The Pulse 120H platform is on display at the Lumenis booth (#1235) at this week’s AUA annual meeting.

    Interested in urology products? Check out these recent articles:

    AUA Exhibit Hall Highlights: Orlando 2014

    New Urology Products and Services May 2014

    New Urology Products and Services April 2014


    To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results